Kim HJ, Oh SH, Kim DY, Lee HS, Park SH, Yang SK, et al. Clinical characteristics and long-term outcomes of paediatric Crohn’s disease: a single-centre experience. J Crohns Colitis. 2017;11(2):157–64.

Article  PubMed  Google Scholar 

Rinawi F, Assa A, Hartman C, Mozer Glassberg Y, Friedler VN, Rosenbach Y, et al. Incidence of bowel surgery and associated risk factors in pediatric-onset Crohn’s disease. Inflamm Bowel Dis. 2016;22(12):2917–23.

Article  PubMed  Google Scholar 

Yerushalmy-Feler A, Assa A. Pharmacological prevention and management of postoperative relapse in pediatric Crohn’s disease. Paediatr Drugs. 2019;21(6):451–60.

Article  PubMed  Google Scholar 

Zarubova K, Hradsky O, Copova I, Rouskova B, Pos L, Skaba R, et al. Endoscopic recurrence 6 months after ileocecal resection in children with Crohn disease treated with azathioprine. J Pediatr Gastroenterol Nutr. 2017;65(2):207–11.

Article  PubMed  CAS  Google Scholar 

Lee KE, Cantrell S, Shen B, Faye AS. Post-operative prevention and monitoring of Crohn’s disease recurrence. Gastroenterol Rep (Oxf). 2022;10: goac070.

Article  PubMed  PubMed Central  Google Scholar 

Beelen EMJ, Nieboer D, Arkenbosch JHC, Regueiro MD, Satsangi J, Ardizzone S, et al. Risk prediction and comparative efficacy of anti-TNF vs thiopurines, for preventing postoperative recurrence in Crohn’s disease: a pooled analysis of 6 trials. Clin Gastroenterol Hepatol. 2022;20(12):2741–52 (e6).

Article  PubMed  CAS  Google Scholar 

Liu C, Li N, Zhan S, Tian Z, Wu D, Li T, et al. Anti-TNFalpha agents in preventing the postoperative recurrence of Crohn’s disease: Do they still play a role in the biological era? Expert Opin Biol Ther. 2021;21(11):1509–24.

Article  PubMed  CAS  Google Scholar 

Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, et al. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn’s disease? Systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36(4):864–72.

Article  PubMed  CAS  Google Scholar 

Bachour SP, Click BH. Clinical update on the prevention and management of postoperative Crohn’s disease recurrence. Curr Gastroenterol Rep. 2024;26(2):41–52.

Article  PubMed  Google Scholar 

Gisbert JP, Chaparro M. Anti-TNF agents and new biological agents (vedolizumab and ustekinumab) in the prevention and treatment of postoperative recurrence after surgery in Crohn’s disease. Drugs. 2023;83(13):1179–205.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Steinberg JM, Chowdhury R, Sharma S, Charabaty A. Biologics, small molecule therapies and surgery in small bowel Crohn’s disease. Curr Opin Gastroenterol. 2024;40(3):203–8.

Article  PubMed  CAS  Google Scholar 

Amil-Dias J, Kolacek S, Turner D, Paerregaard A, Rintala R, Afzal NA, et al. Surgical management of Crohn disease in children: guidelines from the paediatric IBD porto group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2017;64(5):818–35.

Article  PubMed  Google Scholar 

Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795–806.

Article  PubMed  CAS  Google Scholar 

Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919.

Article  PubMed  PubMed Central  Google Scholar 

Spencer EA, Jarchin L, Rolfes P, Khaitov S, Greenstein A, Dubinsky MC. Outcomes of primary ileocolic resection for pediatric Crohn disease in the biologic era. J Pediatr Gastroenterol Nutr. 2021;73(6):710–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dreznik Y, Samuk I, Shouval DS, Paran M, Matar M, Shamir R, et al. Recurrence rates following ileo-colic resection in pediatric patients with Crohn’s disease. Pediatr Surg Int. 2023;39(1):83.

Article  PubMed  Google Scholar 

Glenisson M, Bonnard A, Berrebi D, Belarbi N, Viala J, Martinez-Vinson C. Complications and disease recurrence after ileocecal resection in pediatric Crohn’s disease: a retrospective study. Eur J Pediatr Surg. 2024;34(3):253–60.

Article  PubMed  CAS  Google Scholar 

Hojsak I, Kolacek S, Hansen LF, Bronsky J, Piekkala M, Lionetti P, et al. Long-term outcomes after elective ileocecal resection in children with active localized Crohn’s disease—a multicenter European study. J Pediatr Surg. 2015;50(10):1630–5.

Article  PubMed  Google Scholar 

Weigl E, Schwerd T, Lurz E, Haberle B, Koletzko S, Hubertus J. Children with localized Crohn’s disease benefit from early ileocecal resection and perioperative anti-tumor necrosis factor therapy. Eur J Pediatr Surg. 2024;34(3):236–44.

Article  PubMed  Google Scholar 

Splawski JB, Pffefferkorn MD, Schaefer ME, Day AS, Soldes OS, Ponsky TA, et al. NASPGHAN clinical report on postoperative recurrence in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2017;65(4):475–86.

Article  PubMed  Google Scholar 

Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 2018;12(1):1–16.

PubMed  Google Scholar 

Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, et al. 3rd european evidence-based consensus on the diagnosis and management of crohn’s disease 2016: part 2: surgical management and special situations. J Crohns Colitis. 2017;11(2):135–49.

Article  PubMed  Google Scholar 

Gomollon F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11(1):3–25.

Article  PubMed  Google Scholar 

Nguyen GC, Loftus EV Jr, Hirano I, Falck-Ytter Y, Singh S, Sultan S, et al. American gastroenterological association institute guideline on the management of Crohn’s disease after surgical resection. Gastroenterology. 2017;152(1):271–5.

Article  PubMed  Google Scholar 

Gallagher J, Rosh JR, Sahn B. The future of advanced therapies for pediatric Crohn’s disease. Paediatr Drugs. 2023;25(6):621–33.

Article  PubMed  Google Scholar 

Gjuladin-Hellon T, Gordon M, Iheozor-Ejiofor Z, Akobeng AK. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn’s disease. Cochrane Database Syst Rev. 2019;6(6): CD008414.

PubMed  Google Scholar 

Peyrin-Biroulet L, Deltenre P, Ardizzone S, D’Haens G, Hanauer SB, Herfarth H, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol. 2009;104(8):2089–96.

Article  PubMed  CAS  Google Scholar 

Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn’s disease. Cochrane Database Syst Rev. 2019;8(8): CD010233.

PubMed  Google Scholar 

Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, et al. Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection. Gastroenterology. 2016;150(7):1568–78.

Article  PubMed  CAS  Google Scholar 

Hirsch A, Scapa E, Fliss-Isakov N, Tulchinsky H, Itzkowitz E, Kariv Y, et al. Early initiation of adalimumab significantly diminishes postoperative Crohn’s disease endoscopic recurrence and is superior to 6-mercaptopurine therapy: an open-label, randomized controlled study. J Clin Med. 2023;12(24):7600.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vuitton L, Peyrin-Biroulet L. Pharmacological prevention of postoperative recurrence in Crohn’s disease. Drugs. 2020;80(4):385–99.

Article  PubMed  CAS  Google Scholar 

Gangwani MK, Nawras M, Aziz M, Rani A, Priyanka F, Dahiya DS, et al. Comparing adalimumab and infliximab in the prevention of postoperative recurrence of Crohn’s disease: a systematic review and meta-analysis. Ann Gastroenterol. 2023;36(3):293–9.

PubMed